Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Gilead Sciences
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Chronic infection with Hepatitis C with HCV RNA \> 1000 IU/mL
Individuals with cirrhosis with Child-Pugh score \< 10
Esophageal or gastric varices on endoscopy within 6 months prior to or at screening
Hepatic Venous Pressure Gradient (HVPG) \> 6 mmHg
Body mass index (BMI) ≥ 18 kg/m\^2
Naïve to all nucleotides/nucleoside treatments for chronic HCV infection
You may not be if
Have any serious or active medical or psychiatric illness which, in the opinion of the investigator, would interfere with subject treatment, assessment, or compliance
HIV or chronic hepatitis B virus (HBV) infection (HBsAg positive)
Alpha-fetoprotein (AFP) \> 50 unless negative imaging for hepatic masses within the last 6 months or during screening
Refractory ascites as defined by requiring paracentesis \> twice within 1 month prior to screening
Active variceal bleeding within 6 months of screening
Expected survival of \< 1 year
History of hepatorenal, or hepatopulmonary syndrome.
Evidence of renal impairment (CrCl \< 50 mL/min)
History of major organ transplantation, including liver transplant.
